Find clinical trials for Alzheimer's Disease in San Francisco, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Alzheimer's Disease trials near San Francisco, CA, USA:
designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's...
Phase 2
Palo Alto, California, United States and 50 other locations
This study is to test LHP588 in persons who have mild to moderate Alzheimer's disease (AD) who have shown progressive mental declin...
Phase 2
Oakland, California, United States and 38 other locations
This study will evaluate the efficacy and safety of trontinemab in participants with biomarker evidence of Alzheimer's Disease (AD)...
Phase 3
Oakland, California, United States of America and 33 other locations
The investigators will study performance on computerized cognitive tasks in healthy participants of different ages to gather normative data for newly...
Berkeley, California, United States
is superior to placebo on change from baseline of the Preclinical Alzheimer Cognitive Composite 5 (PACC5) at 216 weeks of treatment (A45 Tri...
Phase 3
San Francisco, California, United States and 108 other locations
This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...
Phase 3
Burlingame, California, United States and 199 other locations
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease...
Phase 3
Palo Alto, California, United States and 128 other locations
This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determin...
Phase 3
San Francisco, California, United States of America and 249 other locations
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's...
Phase 3
Napa, California, United States and 144 other locations
Development of novel disease-modifying therapies for Alzheimer's disease (AD) remains of paramount importance. This study ...
Phase 2
Walnut Creek, California, United States and 1 other location
Clinical trials
Research sites
Resources
Legal